Valuation

STVNStevanato Group S.p.A.

StockNYSEItalyHealth careEU retail: available

−1.1% today · −24.4% over a year

2/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 42% of the instruments we score

Priced higher than most peers (P/E 37.8). Dividend yield 0.32%.

Stevanato Group S.p.A. (STVN) valuation against sector peers: P/E 37.8 (sector median 22.4), P/B 3.6, EV/EBIT 28.2, free-cash-flow yield 0.4%, P/S 4.5.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricSTVNSector medianvs median
P/E37.822.4 · n=2868% above
P/B3.63.6 · n=45near the median
P/S4.54.5 · n=40near the median
EV/EBIT28.220.8 · n=2835% above
Free-cash-flow yield0.4%3.5% · n=4188% below
Dividend yield0.32%0.12% · n=100167% above
Return on equity9.7%6.8% · n=5643% above
Return on invested capital8.3%7.0% · n=4719% above
Gross margin29.0%70.2% · n=3959% below
Net debt / EBITDA1.091.39 · n=2622% below

Value factor: 40 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

NVSNovartis AG21.36.517.95.9%2.5%9/10
NOVNNovartis AG21.26.417.85.9%2.9%10/10
AZNAstraZeneca plc25.75.420.94.5%1.9%6/10
AZNAstraZeneca PLC25.75.420.94.5%1.3%6/10
NVONovo Nordisk A/S11.25.99.85.2%4.8%7/10
GSKGSK plc13.84.811.38.1%3.7%10/10
SNYSanofi11.81.316.37.8%5.0%7/10
SANSanofi SA11.81.316.27.8%5.5%8/10
TEVATeva Pharmaceutical Industries Limited66.06.037.22.9%0.0%6/10
ALCAlcon34.71.527.35.1%0.4%4/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 31 Dec 2025 · filed 04 Mar 2026